Sign In
Section Navigation
Common TitleDOMONO
Official Title The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial
Phase Phase IV
ClinicalTrials.gov NCT02401828
Treatments
Dolutegravir
Dolutegravir Tivicay

Dolutegravir

Tradename:TivicayOther Names:DTGClass:Integrase Strand Transfer Inhibitors (INSTI)
Categories Treatment-ExperiencedSwitch/SimplificationMonotherapy
Funding
Non-IndustryErasmus Medical Center
References
  • Wijting I, Rokx C, Boucher C, et al. Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial. Lancet HIV. 2017;4:e547-e554.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.